Description: This case follows a long line of cases decided in light of Engle v. Liggett
Group, Inc. (Engle III), 945 So. 2d 1246 (Fla. 2006). In Engle, a group of smokers
and their survivors filed a class action against major tobacco companies for
damages allegedly caused by smoking-related injuries. Id. at 1256.2 Among other
things, the class sought compensatory damages based on various theories,
including strict liability and negligence.
After certification of the class in R.J. Reynolds Tobacco Co. v. Engle
(Engle I), 672 So. 2d 39 (Fla. 3d DCA 1996), the trial court developed a three
phase trial plan. Phase I consisted of a year-long jury trial to determine issues
related to liability and entitlement to punitive damages. Liggett Grp. Inc. v. Engle
(Engle II), 853 So. 2d 434, 441 (Fla. 3d DCA 2003). The jury considered issues
common to the entire class, including the defendants’ conduct, general causation,
and the effects of smoking on health. Id. The jury returned a verdict in favor of
the class on all counts and determined that the Engle defendants’ actions entitled
the class to punitive damages. Id.
In Phase II, the same jury decided the individual causation and damages for
the class representatives, as well as the amount of punitive damages to be awarded
to the entire class. Id. The jury found that the class representatives were entitled
to compensatory damages, and awarded class-wide punitive damages in the
amount of $145 billion.3
Institute, Inc., and Brooke Group, Ltd., Inc. See R.J. Reynolds Tobacco Co. v. Engle, 672 So. 2d 39, 39 (Fla. 3d DCA 1996).
3. This Court later held that the punitive damages award was both clearly excessive and premature because, although the Phase I jury decided the Engle defendants’ common liability to the class under certain claims, it did not decide the plaintiff-specific elements of those claims and, therefore, “did not determine
- 4 -
The plan for Phase III was to have different juries decide the individual
causation and damages for each class member, but prior to the start of Phase III,
the class was decertified “because individualized issues such as legal causation,
comparative fault, and damages predominate[d].” Engle III, 945 So. 2d at 1268.
This Court held that individual class members could initiate individual actions
against the Engle defendants “within one year of the issuance of [Engle III] with
res judicata effect given to certain Phase I findings.” Id. at 1254.
Specifically, this Court held that the following Phase I findings were entitled
to res judicata effect: (1) smoking cigarettes causes certain enumerated diseases,
including lung cancer; (2) nicotine is addictive; (3) the Engle “defendants placed
cigarettes on the market that were defective and unreasonably dangerous”; (4) the
Engle defendants “concealed or omitted material information not otherwise known
or available knowing that the material was false or misleading or failed to disclose
a material fact concerning the health effects or addictive nature of smoking
cigarettes or both”; (5) the Engle “defendants agreed to conceal or omit
information regarding the health effects of cigarettes or their addictive nature with
the intention that smokers and the public would rely on this information to their
detriment”; (6) “all of the [Engle] defendants sold or supplied cigarettes that were
whether the defendants were liable to anyone.” Engle III, 945 So. 2d at 1263 (quoting Engle II, 853 So. 2d at 450).
- 5 -
defective”; (7) “all of the [Engle] defendants sold or supplied cigarettes that, at the
time of sale or supply, did not conform to representations of fact made by said
defendants”; and (8) “all of the [Engle] defendants were negligent.” Id. at 1276
77. However, this Court disapproved the use of the Phase I findings relating to
intentional infliction of emotional distress, fraud and misrepresentation, and civil
conspiracy based on misrepresentation because the nonspecific findings were
“inadequate to allow a subsequent jury to consider individual questions of reliance
and legal cause.” Id. at 1255.
After Engle III was issued, there was some confusion among the courts
regarding whether the Phase I findings were to be given the effect of claim
preclusion or issue preclusion. This Court clarified that the “res judicata” effect in
Engle III is claim preclusion, not issue preclusion. Philip Morris USA, Inc. v.
Douglas, 110 So. 3d 419, 432 (Fla. 2013).
FACTS AND PROCEDURAL BACKGROUND
The representative for the estate of Phil Felice Marotta (Marotta) filed an
action as an Engle progeny plaintiff against R.J. Reynolds Tobacco Company
(Reynolds), an Engle defendant, asserting that Marotta’s addiction to Reynolds’
cigarettes caused his death by lung cancer. Marotta raised several claims based on
the Engle Phase I findings, including strict liability, negligence, concealment, and
conspiracy. The jury found Reynolds liable on the strict liability claim, but not on
- 6 -
the negligence, concealment, or conspiracy claims. The jury assigned 58% of the
fault to Reynolds and 42% to Marotta and awarded total compensatory damages of
$6 million (reduced to $3.48 million to reflect comparative fault determinations).
Reynolds appealed the final judgment, and Marotta cross-appealed the trial court’s
decision to preclude the jury from considering punitive damages on the product
liability claim. Marotta, 182 So. 3d at 830.
On appeal, the Fourth District affirmed. Id. In its opinion, the court wrote
to specifically address Reynolds’ argument that “because Congress has expressly
sanctioned the sale of cigarettes, and because the practical effect of the Engle
progeny litigation is to establish that all cigarettes are inherently dangerous and
defective, strict liability and negligence claims are implicitly preempted by federal
law allowing the sale of cigarettes.” Id. at 831. The district court did not find
merit in this argument, explaining that only certain tobacco claims are preempted
by federal law, and “[w]hether a state law claim is preempted is dependent on the
exact nature of that particular claim.” Id. (quoting Spain v. Brown & Williamson
Tobacco Corp., 363 F.3d 1183, 1193 (11th Cir. 2004)). Federal law provides that
“[n]o requirement or prohibition based on smoking and health shall be imposed
under State law with respect to the advertising or promotion of any cigarettes the
packages of which are labeled in conformity with the provisions of this chapter.”
15 U.S.C. § 1334(b) (2012) (emphasis added). The district court therefore
- 7 -
concluded that “[t]he central inquiry in each [preemption] case is . . . whether the
legal duty that is the predicate of the common-law damages action constitutes a
‘requirement or prohibition based on smoking and health . . . imposed under State
law with respect to . . . advertising or promotion.’ ” Marotta, 182 So. 3d at 831
(quoting Cipollone v. Liggett Grp., Inc., 505 U.S. 504, 523-24 (1992) (plurality
opinion) (quoting 15 U.S.C. § 1334(b) (1988))). The district court therefore
concluded that only state law claims related to the advertisement and promotion of
cigarettes are preempted, but strict liability and negligence claims are not. Id. at
The district court in Marotta acknowledged that the United States Court of
Appeals for the Eleventh Circuit recently reached the opposite conclusion in
Graham v. R.J. Reynolds Tobacco Co., 782 F.3d 1261 (11th Cir. 2015), reh’g en
banc granted, opinion vacated, 811 F.3d 434 (11th Cir. 2016). In Graham, the
federal court held that Engle progeny product liability claims are implicitly
preempted by federal law. Id. at 1280. The court determined that the Engle
“Phase I findings regarding strict-liability and negligence amount to the bare
assertion that cigarettes are inherently defective—and cigarette manufacturers
inherently negligent—because cigarettes are addictive and cause disease.” Id. at
1281. The court concluded that Engle “imposed a common-law duty on cigarette
manufacturers that they necessarily breached every time they placed a cigarette on
- 8 -
the market,” and because such a duty operates as a ban on cigarettes, “it conflicts
with Congress’s clear purpose and objective of regulating—not banning—
cigarettes.” Id. at 1282. However, the circuit court conceded that federal law does
not preempt all state law tort claims against tobacco companies; rather, it only
preempts those claims that rely solely on Engle Phase I findings or are based on a
theory of liability that all cigarettes are defective as a matter of law. Id. at 1284.
The Marotta court disagreed with the decision in Graham for several
reasons. First, Marotta determined that Graham “overstates the effect of the past
ten years of Florida tobacco case law by equating it to a ban on cigarette sales.”
Marotta, 182 So. 3d at 832. Second, Marotta disagreed with the Eleventh Circuit’s
conclusion that state governments cannot ban a product that Congress has chosen
to regulate, stating it amounted to a blanket argument that “cannot withstand the
test of experience and logic,” citing federal regulation of alcohol as an example.
Id. at 833. Further, the district court in Marotta noted that Graham relied in part on
the Federal Cigarette Labeling and Advertising Act of 1965 (1965 Act or FCLAA),
Pub. L. No. 89-92, 79 Stat. 282 (1965), to conclude that Congress intended to
prevent states from banning the sale of cigarettes. See Graham, 782 F.3d at 1277
78. The district court in Marotta disagreed with the assertion that the FCLAA
indicates any congressional “intent to preempt states from banning the sale of
cigarettes, a state right traditionally reserved within a state’s police powers, or
- 9 -
from permitting state tort claims relating to the production and sale of cigarettes.”
Marotta, 182 So. 3d at 833. The district court concluded that the FCLAA only
demonstrates Congress’s intent to establish uniform labeling and advertising
requirements by preventing states from imposing their own requirements, a result
that would have created a burden on the interstate commerce of cigarettes. Id.
The district court in Marotta also noted that Graham relied in part on a
provision of the 2009 Family Smoking Prevention and Tobacco Control Act
(FSPTCA), Pub. L. No. 111-31, 123 Stat. 1776 (2009), codified as 21 U.S.C.
§ 387a (2012), which grants the Food and Drug Administration (FDA) authority to
regulate cigarettes, but specifically prohibits the FDA from banning them. See
Graham, 782 F.3d at 1278-79. However, the district court observed that the
FSPTCA contains no such prohibition on states from banning cigarettes. Marotta,
182 So. 3d at 833. The district court explained that, although the FSPTCA
“expressly preempts states from regulating certain aspects of cigarette commerce,
such as labeling and manufacturing, it [also] specifically acknowledges states’
rights to regulate other aspects of tobacco, including a state’s right to prohibit the
sale of tobacco.” Id. The district court concluded:
[B]ecause Engle progeny cases do not support a conclusion that strict product liability claims amount to a ban on the sale of cigarettes, and because federal tobacco laws expressly preserve a state’s ability to regulate tobacco in ways other than manufacturing and labeling while declining to “modify or otherwise affect any action or the liability of any person under the product liability law of any State,” we find no
- 10 -
conflict between the applicable state and federal laws. Accordingly, the trial court did not err in rejecting the defendant’s argument that negligence and strict liability claims are preempted by federal law.
Id. at 834. Nevertheless, the district court certified the question to this Court in
acknowledgement of Graham’s contrary holding. This review follows.
Whether state law is preempted by federal law is a pure question of law
subject to de novo review. Vreeland v. Ferrer, 71 So. 3d 70, 73 (Fla. 2011).
The certified question in this case asks whether federal law implicitly
preempts Marotta’s strict liability and negligence claims as an Engle progeny
plaintiff based on the sale of cigarettes. Reynolds contends that Congress, through
decades of legislation, has established its intention to regulate cigarettes while
foreclosing their removal from the market, and that any state law that conflicts
with this objective is implicitly preempted. Reynolds argues that imposing tort
liability for the sale of ordinary cigarettes amounts to a ban, and therefore such
claims are preempted. Further, Reynolds insists that the liability imposed in Engle
and Engle progeny cases was based on the inherent characteristics of cigarettes
(namely, the presence of nicotine, which causes addiction and disease), thereby
holding cigarette manufacturers liable for selling products that are sanctioned and
protected by Congress.
- 11 -
In answering the certified question, we consider: (1) whether and to what
extent federal law preempts state law tort claims against tobacco companies; and
(2) whether Engle Phase I findings are based on the inherent characteristics of
cigarettes such that these findings amount to a functional ban.
Whether and to what extent federal law preempts state law tort claims against cigarette manufacturers
Reynolds argues that Congress has completely foreclosed the removal of
cigarettes from the market, and therefore any state action that attempts to do so is
preempted. In other words, Reynolds argues that because Congress chose to
regulate but not ban cigarettes, it intended to continue their manufacture and sale
and, therefore, preempt state law claims based on such manufacture and sale. An
initial question, then, is whether Congress intended to preclude the States from
banning cigarettes, or more narrowly, whether it intended to preempt state law
strict liability and negligence claims against cigarette manufacturers.
Federal preemption arises under three circumstances: (1) where Congress
has expressly preempted state law; (2) where state law attempts to regulate a field
that Congress intended the federal government to occupy exclusively; or (3) where
state law actually conflicts with federal law, either because it would be impossible
to comply with both federal and state regulations, or because the state regulation
“stands as an obstacle to the accomplishment and execution of the full purposes
and objectives of Congress.” Vreeland, 71 So. 3d at 76 (quoting Hillsborough Cty.
- 12 -
v. Automated Med. Labs, Inc., 471 U.S. 707, 713 (1985)). At issue in Marotta is
the latter form of conflict preemption, also known as obstacle preemption. It is
therefore critical to ascertain the purposes and objectives of Congress, and whether
the state law tort claims at issue “stand as an obstacle” to those purposes and
objectives. However, there is a strong presumption against preemption, and “a
high threshold must be met if a state law is to be pre-empted for conflicting with
the purposes of a federal Act.” Chamber of Commerce v. Whiting, 563 U.S. 582,
607 (2011) (plurality opinion) (quoting Gade v. Nat’l Solid Wastes Mgmt. Ass’n,
505 U.S. 88, 110 (Kennedy, J., concurring in part and concurring in judgment)). A
preemption analysis begins “with the assumption that the historic police powers of
the States were not to be superseded by [federal law] unless that was the clear and
manifest purpose of Congress.” Rice v. Santa Fe Elevator Corp., 331 U.S. 218,
Congressional purpose is “the ultimate touchstone in every pre-emption
case.” Vreeland, 71 So. 3d at 77 (quoting Altria Grp., Inc. v. Good, 555 U.S. 70,
76 (2008)). Accordingly, we must first determine Congress’s objectives in
regulating tobacco products, and whether such objectives are impeded by the
imposition of tort liability for injury caused by cigarettes.
Congress first addressed the health effects of cigarettes with the enactment
of the FCLAA in 1965. The Act’s express purpose is twofold: (1) to inform the
- 13 -
public that smoking cigarettes is a health hazard, and (2) to protect the tobacco
industry from the burdens of complying with contradictory state regulations
regarding the labels and advertisements of their products. Pub. L. No. 89-92, § 2,
79 Stat. 282, 282 (1965) (codified at 15 U.S.C. § 1331 (2012)). To accomplish this
purpose, the FCLAA both mandated warnings on cigarette packages and expressly
preempted state laws that would impose different or additional labeling or
advertising requirements. Id. §§ 4-5.
In 1969, Congress amended the FCLAA with the Public Health Cigarette
Smoking Act of 1969 (1969 Act), Pub. L. No. 91-222, 84 Stat. 87 (1970). The
1969 Act tightened regulations by strengthening warning labels and banning radio
and television advertising of cigarettes. The 1969 Act also modified the federal
preemption provision. The legislative history indicates that the reason for the
modification was to clarify that “preemption is intended to include not only action
by State statute but by all other administrative actions or local ordinances.”
S. Rep. No. 91-566 (1969), as reprinted in 1970 U.S.C.C.A.N. 2652, 2663. The
Senate Report further notes that “[t]he State preemption of regulation or
prohibition with respect to cigarette advertising is narrowly phrased to preempt
only state action based on smoking and health. It would in no way affect the
4. “No requirement or prohibition based on smoking and health shall be imposed under State law with respect to the advertising or promotion of any
- 14 -
power of any State . . . with respect to the taxation or the sale of cigarettes to
minors, or the prohibition of smoking in public buildings, or similar police
regulations. It is limited entirely to State or local requirements or prohibitions in
the advertising of cigarettes.” Id.
The FCLAA was amended again in 1984 when Congress passed the
Comprehensive Smoking Education Act with the stated purpose of “making
Americans more aware of any adverse health effects of smoking, to assure the
timely and widespread dissemination of research findings and to enable individuals
to make informed decisions about smoking.” Pub. L. No. 98-474, § 2, 98 Stat.
2200, 2200 (1984). The Comprehensive Smoking Education Act amended
cigarette labeling requirements and compelled the Secretary of Health and Human
Services to research and report on the effects of cigarette smoking. See 15 U.S.C.
§§ 1333(a), 1341(a) (2012).
In 2009, the FSPTCA was signed into law. The FSPTCA accomplished a
number of things, but most importantly, it gave the FDA authority to regulate
tobacco products. 21 U.S.C. § 387a (2012). The FDA’s authority is not unlimited,
however. Among other things, the FDA may not ban tobacco products. Id.
cigarettes the packages of which are labeled in conformity with the provisions of this chapter.” 15 U.S.C. § 1334(b) (2012).
- 15 -
§ 387g(d)(3). Importantly, the FSPTCA also included a savings clause that
preserved certain state powers related to tobacco regulation. See id. § 387p(a).
Reynolds asserts that through this legislation, Congress has made a
deliberate choice to protect the market for ordinary cigarettes, despite their known
and inherent health and addiction risks. Reynolds cites the United States Supreme
Court’s decision in FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120
(2000), for the proposition that states may not ban cigarettes because “Congress
. . . has foreclosed the removal of tobacco products from the market.” Id. at 137.
However, while it is clear Brown & Williamson held that the FDA was foreclosed
from banning cigarettes,5 it is also clear that this holding does not extend to the
states. In Brown & Williamson, a group of tobacco companies filed an action
against the FDA for regulations it promulgated concerning tobacco products’
promotion, labeling, and accessibility to children and adolescents. Id. at 128-29.
The FDA promulgated the regulations based on its determination that it had the
authority to do so because “nicotine is a ‘drug’ and . . . cigarettes . . . are ‘drug
delivery devices,’ and therefore it had jurisdiction under the FDCA [Food, Drug,
and Cosmetic Act] to regulate tobacco products.” Id. at 127. The tobacco
companies argued that the regulations were beyond the FDA’s jurisdiction because
5. Brown & Williamson was decided before the enactment of the FSPTCA, which granted the FDA the authority to regulate tobacco products.
- 16 -
Congress had not granted the FDA the authority to regulate tobacco. Id. at 129-30.
Considering the FDCA as a whole, the Supreme Court agreed, and concluded that
Congress intended to exclude tobacco products from the FDA’s jurisdiction. Id. at
133-34, 142. In reaching its decision, the Court observed that “[a] fundamental
precept of the FDCA is that any product regulated by the FDA—but not banned—
must be safe for its intended use.” Id. at 142. The FDA had already “exhaustively
documented that ‘tobacco products are unsafe,’ ‘dangerous,’ and ‘cause great pain
and suffering from illness.’ ” Id. at 134 (quoting Restricting Sale and Distribution
of Cigarettes and Smokeless Tobacco, 61 Fed. Reg. 44,396, 44,412 (1996)). The
Court explained that if tobacco products were within the FDA’s jurisdiction, they
would have to be banned because it would be impossible to prove they were safe
for their intended use. Id. at 135. The Court determined that Congress had
foreclosed such a ban, choosing instead to create a distinct regulatory scheme
focusing on the labeling and advertising of tobacco products. Id. at 155.
Therefore, the Supreme Court concluded that Congress intended to exclude
tobacco products from the FDA’s jurisdiction because a ban by the FDA would
contradict congressional policy. Id. at 142.
However, while Brown & Williamson held that the FDA did not have the
authority to regulate tobacco products, it said nothing about the states’ power to do
the same. The Supreme Court’s analysis focused primarily on whether Congress
- 17 -
had granted the FDA, as a federal agency, such regulatory authority. See Berger v.
Philip Morris USA, Inc., 185 F. Supp. 3d 1324 (M.D. Fla. 2016), appeal docketed,
No. 16-15957 (11th Cir. Ct. Sept. 13, 2016). In Berger, the United States District
Court for the Middle District of Florida stated:
Brown & Williamson is not a case about preemption of state law. It is, rather, a case about whether Congress delegated authority to an executive agency to promulgate rules about and regulations relating to tobacco. Such delegation implicates congressional goals for what it wanted federal law to achieve or not to achieve.
. . . Brown & Williamson’s discussion of congressional objectives with respect to cigarettes supports only the unremarkable contention that Congress itself did not wish to remove cigarettes from the national market. It does not support the more extreme inference that Congress intended to displace state police powers in regulating cigarettes.
Id. at 1341 (citations omitted). We agree with this conclusion reached by the
Reynolds further asserts that the imposition of tort liability for the sale of
cigarettes would undermine Congress’s express intention under the FCLAA to
protect the “commerce and national economy” of the tobacco industry. However,
the context in which Congress enacted the FCLAA is helpful in interpreting
congressional intentions. In 1964, the Surgeon General’s Advisory Committee
issued a report discussing the hazard that cigarette smoking poses to health. As a
result, the Federal Trade Commission (FTC) and several states moved quickly to
- 18 -
regulate the advertising and labeling of cigarettes. See Cipollone, 505 U.S. at 513.
In response to the actions by the FTC and the states, Congress enacted the FCLAA
the following year. See Richardson v. R.J. Reynolds Tobacco Co., 578 F. Supp. 2d
1073, 1077 n.2 (E.D. Wisc. 2008). “Thus, Congress clearly intended to ‘protect
the national economy from the burden imposed by diverse, nonuniform, and
confusing cigarette labeling and advertising regulations,’ but did not clearly intend
to extend broad immunity from common law liability to cigarette manufacturers.”
Id. at 1077 (quoting Cipollone, 505 U.S. at 514).
Further, the majority of state6 and federal7 court decisions that have
addressed the question of federal preemption in tobacco product liability cases
6. See, e.g., Cantley v. Lorillard Tobacco Co., 681 So. 2d 1057 (Ala. 1996) (smoker’s fraudulent suppression claim based on state law duty to disclose was preempted by FCLAA, but defective design claim was not); People ex rel. Lockyer v. R.J. Reynolds Tobacco Co., 124 P.3d 408 (Cal. 2005) (FCLAA did not preempt state statute regulating free distribution of cigarettes); Forster v. R.J. Reynolds Tobacco Co., 437 N.W.2d 655 (Minn. 1989) (FCLAA preempts failure to warn claims, but not state law claims for strict liability for unsafe design of cigarette or defective conditions; negligence claim preempted only to extent it was based on breach of duty to warn about hazards of smoking); American Tobacco Co. v. Grinnell, 951 S.W.2d 420 (Tex. 1997) (FCLAA and 1969 Act preempted strict liability and negligence claims only to extent they were related to advertising, promotion, or failure to warn).
7. See, e.g., Altria Grp., Inc. v. Good, 555 U.S. 70, 91 (2008) (FCLAA “does not pre-empt state-law claims . . . that are predicated on the duty not to deceive” because such regulations do not pertain to the content of any advertising); Spain v. Brown & Williamson Tobacco Corp., 363 F.3d 1183 (11th Cir. 2004) (state law breach of warranty claim was not preempted by FCLAA); Richardson v.
- 19 -
have held that Congress only intended to preempt state laws to the extent that they
relate to labeling or advertising of tobacco products. Indeed, a plurality of the
United States Supreme Court came to this conclusion after examining the scope of
the preemption provisions within the FCLAA and the 1969 Act. Cipollone, 505
U.S. 504. In Cipollone, a smoker filed an action in federal court against cigarette
manufacturers under various theories, including strict liability and negligence. Id.
at 509. The tobacco companies argued that the FCLAA and the 1969 Act
preempted Cipollone’s common law tort claims and protected their conduct after
1965. Id. at 510. The Court compared the precise language of the 1965
preemption provision8 with the broader language contained in the 1969 revisions.9
Cipollone, 505 U.S. at 520. A majority of the Court held that “the 1965 Act only
pre-empted state and federal rulemaking bodies from mandating particular
R.J. Reynolds Tobacco Co., 578 F. Supp. 2d 1073, 1076 (E.D. Wisc. 2008) (“[T]he FCLAA preempts only claims related to advertising and promotion.”).
8. “No statement relating to smoking and health shall be required in the advertising of any cigarettes the packages of which are labeled in conformity with the provisions of this chapter.” 15 U.S.C. § 1334(b) (Supp. III 1964) (emphasis added).
9. “No requirement or prohibition based on smoking and health shall be imposed under State law with respect to the advertising or promotion of any cigarettes the packages of which are labeled in conformity with the provisions of this chapter.” 15 U.S.C. § 1334(b) (1982) (emphasis added).
- 20 -
cautionary statements and did not pre-empt state-law damages actions.” Id. at 519
20. The Court observed:
[T]here is no general, inherent conflict between federal pre-emption of state warning requirements and the continued vitality of state common-law damages actions. For example, in the Comprehensive Smokeless Tobacco Health Education Act of 1986, Congress expressly pre-empted state or local imposition of a “statement relating to the use of smokeless tobacco products and health” but, at the same time, preserved state-law damages actions based on those products.
Id. at 518 (footnote omitted). The Court also noted that such a reading comports
with the 1965 Act’s purpose to avoid “diverse, nonuniform, and confusing
cigarette labeling and advertising regulations with respect to any relationship
between smoking and health.” Id. at 519 (emphasis omitted) (quoting 1965 Act
§ 2). However, the Court was divided as to how the amended language in the 1969
Act affected the scope of federal preemption. The plurality determined that the
Act does not preempt all common law claims, such as “state-law obligations to
avoid marketing cigarettes with manufacturing defects or to use a demonstrably
safer alternative design for cigarettes.” Id. at 523. The plurality concluded that the
question of preemption is case and claim specific:
[W]e must fairly but—in light of the strong presumption against preemption—narrowly construe the precise language of [the Act’s preemption provision] and we must look to each of petitioner’s common-law claims to determine whether it is in fact pre-empted. The central inquiry in each case is straightforward: we ask whether the legal duty that is the predicate of the common-law damages action constitutes a “requirement or prohibition based on smoking and health
- 21 -
. . . imposed under State law with respect to . . . advertising or promotion,” giving that clause a fair but narrow reading.
Id. at 523-24 (plurality opinion) (footnote omitted) (quoting 1969 Act § 5(b)). The
plurality determined that the 1969 Act preempted the petitioner’s “claims based on
a failure to warn and the neutralization of federally mandated warnings to the
extent that those claims rely on omissions or inclusions in respondents’ advertising
or promotions,” but not the petitioner’s express warranty, intentional fraud and
misrepresentation, and conspiracy claims. Id. at 530-31.
Overall, the history of federal tobacco legislation shows that Congress
sought to create a balanced regulatory scheme, first and foremost to educate the
public about the health hazards of smoking, and “[s]econdarily, . . . to create
uniform rules regarding the regulation of tobacco advertising, to recognize the
economic importance of the tobacco industry and to confirm the individual’s ‘right
to choose to smoke or not to smoke.’ ” Richardson, 578 F. Supp. 2d at 1078
(quoting H.R. Rep. No. 89-449 (1965) as reprinted in 1965 U.S.C.C.A.N. 2350,
2352). We hold that permitting Engle progeny plaintiffs to bring state law strict
liability and negligence claims against Engle defendants does not conflict with
these objectives. While Congress did expressly preempt state and local regulations
pertaining to the labeling and advertising of cigarettes, there is no indication that
Congress had a “clear and manifest purpose” to insulate the tobacco industry from
- 22 -
state tort liability. Strict liability and negligence claims, such as those brought by
Marotta under Engle, do not interfere with the regulation of advertising and
promotion of cigarettes and, therefore, do not clearly conflict with congressional
objectives. This determination is consistent with congressional intent as evidenced
by Congress’s explicitly stated purpose of the FCLAA, and also with the inclusion
of “savings clauses” in the legislation that preserves product liability actions under
state law. See 21 U.S.C. § 387p(a)(1), (b) (Supp. 2009); 15 U.S.C. § 4406(c)
(2006). While Reynolds argues that these acts—and consequently, their savings
clauses—are inapplicable here by their own terms (namely, that 15 U.S.C. § 4406
governs only smokeless tobacco, and 21 U.S.C. § 387p was enacted in 2009 and
does not apply to cases pending before its effective date), we conclude that the
inclusion of these clauses is indicative of Congress’s general intent to preserve
state law tort remedies against cigarette manufacturers.
Factual Basis for Engle Phase I Findings
Even if Congress did intend to prevent the states from banning cigarettes, it
is clear that tort liability like that in Engle does not amount to such a ban.
Reynolds’ entire preemption argument is based on its assertion that Engle imposes
liability for the sale of “ordinary” cigarettes containing nicotine.10 Reynolds
10. The certified question itself focuses on this aspect of Reynolds’ argument, asking “[w]hether federal law implicitly preempts state law tort claims
- 23 -
argues that imposing tort liability based on the inherent risks involved with
smoking amounts to a ban on cigarettes because it creates a common law duty that
tobacco companies necessarily breach every time they place a cigarette on the
market. Reynolds therefore concludes that because Congress has foreclosed the
removal of tobacco from the market, these state tort claims that equate to a ban are
impliedly preempted by federal law. However, Reynolds concedes that federal law
does not preempt all product liability claims against cigarette manufacturers, such
as those based on a theory of defect narrower than the inherent dangerousness of
all cigarettes. Therefore, a critical question is whether Engle defendants’ liability
is based solely on the inherent dangers of cigarettes. We hold that it is not.
Several aspects of Engle, such as the class complaint, the verdict form
instructions, and the Phase I jury findings, indicate that the inherent characteristics
of all cigarettes did not form the sole basis for liability. Rather, the case was
premised on the allegation that the Engle defendants intentionally increased the
amount of nicotine in their products to ensure that consumers became addicted.
First, as the Engle class complaint itself demonstrates, class members did not
allege that the defendants should be held liable solely because of the inherent
dangers of all cigarettes. For example, the named defendants did not include all
of strict liability and negligence . . . based on the sale of cigarettes.” Marotta, 182 So. 3d at 834 (emphasis added).
- 24 -
cigarette manufacturers or distributers who sold cigarettes in Florida. Instead, the
complaint described the defendants as “manufacturers and distributors of tobacco
products . . . containing the chemical nicotine; said Defendants manipulated the
level of nicotine in their tobacco products so as to make these products addictive.”
(emphasis added). Amended Class Action Complaint for Compensatory and
Punitive Damages at 8-9, Engle v. R.J. Reynolds Tobacco Co., No. 94-08273 CA
(Fla. 11th Cir. Ct. May 10, 1994). Likewise, the class members did not consist of
every consumer of defendants’ cigarettes. Instead, the class was described as those
consumers who were addicted to cigarettes, continued to smoke and were unable to
quit because of their addiction, and suffered death or disease as a result.11
In addition, the complaint alleges repeatedly that the defendants
intentionally manipulated nicotine levels in their products. For example, the
common questions of fact and law asked whether the defendants “manipulated the
levels of nicotine in their tobacco products”; “intentionally caused the level of
nicotine to rise in low tar cigarettes so as to keep smokers of low tar cigarettes
addicted to nicotine”; “intentionally miscalculate[d] and inaccurately measure[d]
the levels of tar and nicotine in cigarettes so as to understate same and deceive the
11. The class was certified as including all Florida “citizens and residents, and their survivors, who have suffered, presently suffer or have died from diseases and medical conditions by their addiction to cigarettes that contain nicotine.” Engle I, 672 So. 2d at 40-42.
- 25 -
consuming public”; and “[w]hether more nicotine is inhaled by the smoker in low
tar cigarettes, due to the intentional manipulation of the level of nicotine and the
design of the cigarette and filter by the [defendants].” Amended Class Action
Complaint at 12-18.
The strict liability claim was based on the allegation that “Defendants’
tobacco products, containing manipulated levels of nicotine, as intentionally
manipulated by these Defendants, which caused Plaintiffs and members of the
class to become addicted to nicotine upon personal consumption, constitute
products that are unreasonably dangerous and defective.” Amended Class Action
Complaint at 38. Likewise, the negligence claim alleged that defendants breached
their duty of reasonable care to the class by:
(a) failure to design and manufacture products that were not addictive; (b) failure to design and manufacture tobacco products that did not contain an unreasonable level of nicotine; . . . (d) failure to take any reasonable precautions or exercise reasonable care to adequately or sufficiently reduce or remove the level of nicotine in cigarettes so that smokers would have the ability to quit; (e) failure to utilize a safer design that was readily available to Defendants, so that smokers could purchase a nicotine free cigarette; (f) failure to utilize accurate measurements as to levels of true nicotine yield and tar in “low tar” cigarettes.
Amended Class Action Complaint at 50-51. It is clear, then, that the class
complaint did not merely allege that the defendants sold their cigarettes despite
knowing that the nicotine within their products was addictive and carcinogenic.
Nor did the complaint allege that the defendants’ cigarettes were defective and
- 26 -
dangerous merely for containing nicotine. Rather, the complaint alleged that the
defendants not only knew that nicotine was addictive and carcinogenic, but
intentionally increased the amount of nicotine in their products to ensure their
consumers became and remained addicted. It alleged that the cigarettes were
defective precisely because of this manipulation.
Second, the Engle Phase I verdict form did not presuppose that all cigarettes
are inherently defective or that all cigarette manufacturers are inherently negligent.
See Berger, 185 F. Supp. 3d at 1334. The jury was first asked to determine if
nicotine is addictive and carcinogenic, and then whether each defendant had placed
cigarettes on the market that were defective and unreasonably dangerous. As the
federal district court in Berger explained:
[I]f strict liability were founded merely on those properties [addictive and carcinogenic], the strict liability question would simply have asked whether each defendant “place[d] cigarettes on the market”— period. But the strict liability inquiry did not end there. The court asked the jury to determine discretely whether each of the seven defendants “place[d] cigarettes on the market that were defective and unreasonably dangerous.” The jury determined that each defendant did. Assuming the jury followed its instructions, what it actually decided is that each defendant’s particular cigarettes were defective, not that all cigarettes are inherently defective.
Id. (citations omitted). Similarly, on the question of negligence, the jury was asked
if each defendant “failed to exercise the degree of care which a reasonable cigarette
manufacturer would exercise under like circumstances.” Verdict Form for Phase I
- 27 -
at 10, Engle v. R.J. Reynolds Tobacco Co., No. 94-08273 CA (Fla. 11th Cir. Ct.
July 7, 1999). This standard assumes that it is possible for cigarettes to be sold in a
reasonable manner. See Philip Morris USA, Inc. v. Lourie, 198 So. 3d 975, 980
(Fla. 2d DCA 2016). Accordingly, the jury was required to determine how a
“reasonable” cigarette manufacturer would behave and whether the Engle
defendants conformed to this standard. Therefore, the verdict form clearly
indicates that the jury found that the Engle defendants’ cigarettes were defective,
not that all cigarettes are inherently defective.
Third, in denying the Engle defendants’ motion for directed verdict, the trial
court’s statements regarding the sufficiency of the evidence indicates that the jury
considered much more than the mere sale of cigarettes containing nicotine:
There was more than sufficient evidence at trial to satisfy the legal requirements of [the strict liability count] and to support the jury verdict that cigarettes manufactured and placed on the market by the defendants were defective in many ways including the fact that the cigarettes contained many carcinogens, nitrosamines, and other deleterious compounds such as carbon monoxide. That levels of nicotine were manipulated, sometime[s] by utilization of ammonia to achieve a desired “free basing effect” of pure nicotine to the brain, and sometime[s] by using a higher nicotine content tobacco called Y-1, and by other means such as manipulation of the levels of tar and nicotine. The evidence more than sufficiently proved that nicotine is an addictive substance which when combined with other deleterious properties, made the cigarette unreasonably dangerous. The evidence also showed some cigarettes were manufactured with the breathing air holes in the filter being too close to the lips so that they were covered by the smoker thereby increasing the amount of the deleterious effect of smoking the cigarette. There was also evidence at trial that some
- 28 -
filters being testmarketed utilize glass fibers that could produce disease and deleterious effects if inhaled by a smoker.
Engle v. R.J. Reynolds Tobacco, No. 94-08273 CA-22, 2000 WL 33534572 at *2
(Fla. 11th Cir. Ct. Nov. 6, 2000) (emphasis added).
In addition, although Marotta’s claims were necessarily based on the Engle
Phase I findings, the record reflects that the jury in this case heard evidence that
Reynolds manipulated the level of nicotine in its cigarettes. For example, an
expert witness for Marotta testified regarding the techniques utilized by the
tobacco industry, including Reynolds, to control the amount of nicotine in their
products.12 In addition, the allegation that Reynolds intentionally engineered its
cigarettes to addict consumers was reiterated to the jury during opening and
Reynolds contends that numerous state and federal decisions have held that
federal law preempts state strict liability and negligence claims against cigarette
manufacturers based on the health and addiction risks of all cigarettes. Reynolds
cites Liggett Group, Inc. v. Davis, 973 So. 2d 467 (Fla. 4th DCA 2007), as an
example. In Davis, plaintiffs filed an action against Liggett under theories of
12. One expert witness for Marotta testified that the level of nicotine in tobacco leaves can be manipulated through the way the tobacco plant is grown (e.g., how tightly the plants are grown together and how much fertilizer is used), and by which tobacco leaves are selected for blending (e.g., top leaves contain more nicotine than lower leaves).
- 29 -
negligence and defective design. Id. at 469. Liability was sought against Liggett
“for continuing to manufacture cigarettes when it became known to Liggett that
they posed a significant danger to the health of smokers.” Id. at 472. The district
court determined that, “[i]f Congress gives express sanction to an activity, the
states cannot declare that activity tortious.” Id. at 471 (quoting Insolia v. Philip
Morris Inc., 128 F. Supp. 2d 1220, 1224 (W.D. Wis. 2000)). The court held that
“the negligence claim based on Liggett’s mere continuing to manufacture
cigarettes is barred by conflict preemption,” because “to allow this claim would be
contrary to Congress’ intent to protect commerce and not to ban tobacco products.”
Id. at 472-73.
However, Davis is distinguishable because it is not an Engle progeny case.
Davis revolved around the premise that liability was sought for the inherent
dangerousness of cigarettes. On the other hand, as previously discussed, the jury
in Engle found that the defendants had placed unreasonably dangerous cigarettes
on the market based on the fact that they had manipulated the nicotine levels in
their products. Further, the Fourth District issued the decisions in both Davis and
Marotta. Read together, the Fourth District has taken the position that civil suits
against tobacco companies are only preempted to the extent that they seek liability
for the sale of “ordinary” cigarettes, but because Engle imposed liability for
something more, progeny claims are not preempted. Indeed, in Davis, the court
- 30 -
observed that “a design defect claim against a cigarette manufacturer is not
preempted by federal statutes.” Id. at 472. Alternatively, to the extent that these
cases do conflict, the difference could be attributed to a change in the Fourth
District’s position regarding implied conflict preemption in tobacco product
liability cases. See Little v. State, 206 So. 2d 9, 10 (Fla. 1968) (holding that where
intradistrict conflict exists, the decision later in time overrules the former as the
decisional law in the district).
Reynolds also argues that Engle tort claims are preempted to the extent that
they seek to impose liability for conduct that Congress has specifically allowed,
citing the United States Supreme Court’s decision in Geier v. American Honda
Motor Co., Inc., 529 U.S. 861 (2000). However, this argument again presupposes
that Engle imposes liability based solely on the inherent characteristics of
cigarettes. As previously discussed, Engle imposed liability for more than the
mere sale of ordinary cigarettes. Additionally, Geier is distinguishable from Engle
and Marotta. In Geier, the Court held that federal law preempted strict liability and
negligence claims based on an automobile manufacturer’s failure to install airbags
because the governing federal regulations specifically allowed manufacturers “a
range of choices among different passive restraint devices,” including, but not
limited to, airbags. Id. at 875. The Court explained that the plaintiffs’ tort action
“depend[ed] upon its claim that manufacturers had a duty to install an airbag” and
- 31 -
“would have required manufacturers of all similar cars to install airbags rather than
other passive restraint systems.” Id. at 881. Because that claim “presented an
obstacle to the variety and mix of devices that the federal regulation sought,” it was
impliedly preempted. Id. This is distinguishable from the federal regulations at
issue here. Federal tobacco regulations have not explicitly allowed the type of
conduct underlying Engle claims, namely, the intentional manipulation of nicotine
levels. Federal regulation does identify a range of acceptable conduct relating to
the advertising and labeling of cigarettes; however, the claims at issue here are not
related to either area. See Berger, 185 F. Supp. 3d at 1341-42 (holding that Engle
progeny plaintiffs’ strict liability and negligence claims were not preempted by
federal law, and distinguishing Geier).
Although Marotta sought punitive damages in his individual action against
Reynolds, the trial court precluded the jury from considering it, and the Fourth
District affirmed on appeal. Marotta, 182 So. 3d at 830. However, later that year,
we issued our decision in Soffer v. R.J. Reynolds Tobacco Co., 187 So. 3d 1219,
1221 (Fla. 2016), holding that “individual members of the Engle class action are
not prevented from seeking punitive damages on all claims properly raised in their
subsequent individual actions.” Therefore, because Soffer was decided after the
- 32 -
Fourth District issued its opinion in Marotta, we quash the Fourth District’s
decision on punitive damages, based on our decision in Soffer.